7
May
2024

Chengdu Yacht Biotechnology Co., Ltd

Exhibitor at CPHI North America 2024 stand 543
About Us

Chengdu Yacht Bio-technology Co.,Ltd is mainly engaged in the R&D, production and sales of APIs, biological drugs and intermediates, involving therapeutic fields such as anti-tumor, anti-infective, immune system, etc. As an important supplier in the industry chain, our subsidiary Sichuan Novals Pharmaceuticals Co., Ltd adheres to the principle of quality and service first and provides customers with high-quality products and solutions. Our main products are Daptomycin, Micafungin, Caspofungin, Everolimus, Dalbavancin, Anidulafungin, ect. 

  • CN
  • 2015
    On CPHI since
  • 1
    Certificates
  • 100 - 249
    Employees
Company types
Pharmaceutical company
Primary activities
API Producer
Generic APIs producer
Contact info
  • NO.7 MANSION, TIANFU LIFE SCIENCE PARK, SOUTH KEYUAN ROAD, CHENGDU SICHUAN, China
Event information
CPHI North America 2024
  • 07 May 2024 - 09 May 2024
  • Pennsylvania Convention Center, Philadelphia
  • Visit us at stand 543

Products Featured at CPHI North America 2024

  • Caspofungin acetate

    Product Caspofungin acetate

    This product is for antifungal. It has been certificated by NMPA.

Chengdu Yacht Bio-technology Co., Ltd Resources (1)

  • Brochure Product list with APIs produced in NMPA/PMDA certified factory

    Chengdu Yacht Bio-technology Co.,Ltd is mainly engaged in the R&D, production and sales of APIs, biological drugs and intermediates, involving therapeutic fields such as anti-tumor, anti-infective, immune system, etc. As an important supplier in the industry chain, our subsidiary Sichuan Novals Pharmaceuticals Co., Ltd adheres to the principle of quality and service first and provides customers with high-quality products and solutions.